Sell RIM!: Against ...
Health Care: Health Services
Abiomed Inc. (ABMD: NASDAQ)
$19.77 0.86 | 4.55%
06/04/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | 472.80 | 25.70 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 49.70 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 19.70 | 12.50 |
| Beta | 1.29 | 0.83 | 0.98 |
| Price to Sales (TTM) | 5.83 | 2.60 | 1.42 |
| Price to Book (MRQ) | 6.26 | 2.62 | 2.41 |
| Price to Tangible Book (MRQ) | 9.04 | 10.66 | 5.08 |
| Price to Cash Flow (TTM) | 625.40 | 15.40 | 9.80 |
| Price to Free Cash Flow (TTM) | -169.30 | 35.90 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 1.70 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.70 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 12.44 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 20.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 30.90 | 12.60 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | 18.00 | 20.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 19.89 | 11.49 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 10.30 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 10.30 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | 8.89 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | n.a. | 4.24 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 4.90 | 1.90 | 1.10 |
| Current Ratio (MRQ) | 5.50 | 2.80 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.30 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.35 | 0.96 |
| Interest Coverage (TTM) | n.a. | 14.90 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | 82.10 | 70.50 | 46.90 |
| Gross Margin - 5 Yr Avg | 79.50 | 69.30 | 47.70 |
| EBITD Margin (TTM) | 1.00 | 28.60 | 18.90 |
| EBITD - 5 Yr Avg | -27.67 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | -1.60 | 18.50 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | -34.60 | 15.70 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | 0.01 | 0.14 | 0.09 |
| Net Profit Margin - 5 Yr Avg | -23.00 | 11.10 | 7.00 |
| Return on Assets (TTM) | -2.00 | 8.40 | 3.10 |
| Return on Assets - 5 Yr Avg | -20.10 | 7.30 | 2.50 |
| Return on Investment (TTM) | -2.40 | 10.90 | 7.90 |
| Return on Investment - 5 Yr Avg | -24.10 | 9.60 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | n.a. | 414,937.00 | 449,376.00 |
| Net Income/Employee (TTM) | n.a. | 56,730.00 | 39,003.00 |
| Receivable Turnover (TTM) | 7.80 | 5.10 | 7.60 |
| Inventory Turnover (TTM) | 2.50 | 2.10 | 8.30 |
| Asset Turnover (TTM) | 0.90 | 0.70 | 0.40 |
Portfolios with ABMD
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- Contributor10 Top Morningstar M&A Stoc...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks At New 52-Week Highs...
- ContributorTop Stocks of the 10 Best M...
- UserPART 6 JPMorgan 28th Annual...
- User52 week high 52 week low
- UserRAPTOR SPRTD-1102091914
- UserPART 5 JPMorgan 27th Annual...
Latest ABMD Headlines from TheStreet
- Abiomed Stock Falls On Unusually High Volume (ABMD) 05.22.12 | 04:05 pm
- Abiomed Stock Gaps Up On Today's Open (ABMD) 05.16.12 | 09:05 am
- Abiomed Stock Hits New 52-Week High (ABMD) 05.01.12 | 10:05 am
- 'Mad Money Lightning Round': Caution on Citigroup 03.02.12 | 07:03 pm
- Abiomed Rises On Unusually High Volume (ABMD) 02.08.12 | 03:02 pm
- Abiomed Stock Falls On Unusually High Volume (ABMD) 02.07.12 | 12:02 pm
- Abiomed Reaches New 52-Week High (ABMD) 02.06.12 | 11:02 am
- 8 Stocks Soaring on Unusual Volume 02.03.12 | 04:02 pm
- Abiomed Stock Gaps Up On Today's Open (ABMD) 02.03.12 | 08:02 am
- 10 Top Morningstar M&A Stock Picks for 2012 01.20.12 | 01:01 pm
Press Releases for ABMD
- Abiomed To Present At Deutsche Bank 37Th Annual Healthcare Conference - Business Wire 05.01.12 | 08:05 am
- Abiomed Receives CE Mark For Impella CVAD - Business Wire 04.12.12 | 08:04 am
- Abiomed Announces First Patient Supported With Impella CVAD - Business Wire 04.03.12 | 08:04 am
- Abiomed Appoints Susan Vissers Lisa As Senior Director Of Investor Relations And Corporate Development - Business Wire 03.21.12 | 08:03 am
- Abiomed Announces Schedule Of Events At American College Of Cardiology 2012 Scientific Sessions - Business Wire 03.20.12 | 08:03 am
- Abiomed To Present At The Cowen 32nd Annual Healthcare Conference - Business Wire 03.02.12 | 11:03 am
- Abiomed To Present At Citi 2012 Global Healthcare Conference - Business Wire 02.22.12 | 08:02 am
- Abiomed Reports Record Revenue Of $32.2 Million And Earnings Of $2.9 Million For Third Quarter Of Fiscal 2012 - Business Wire 02.03.12 | 07:02 am
- New Clinical Data For Symphony Presented In Late Breaking Clinical Trials Session At The Society Of Thoracic Surgeons 2012 Annual Meeting - Business Wire 01.31.12 | 08:01 am
- Abiomed Third Quarter Fiscal 2012 Earnings And Conference Call Notification - Business Wire 01.26.12 | 12:01 pm
Partner Headlines for ABMD
- Abiomed Beats, Posts Profit - Analyst Blog - Zacks 05.17.12 | 10:05 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 04.09.12 | 09:04 am
- Abiomed Tops, Swings to Black - Analyst Blog - Zacks 02.06.12 | 09:02 am
- Wunderlich Maintains Buy, $24 Target on Abiomed - Benzinga 12.12.11 | 09:12 am
- Abiomed Raised to Outperform - Analyst Blog - Zacks 11.11.11 | 07:11 pm
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 11.07.11 | 09:11 am
- Neutral View on Abiomed - Analyst Blog - Zacks 08.16.11 | 06:08 pm
- Healthcare Stocks in the News on Tuesday - Seeking Alpha 06.29.11 | 09:06 am
- UPDATE 1-US FDA warns Abiomed on marketing of heart pump - Reuters 06.28.11 | 11:06 am
- Cramer's Mad Money - 6 Earnings to Watch in the Coming Week (6/3/11) - Seeking Alpha 06.05.11 | 06:06 am
